Open Access Open Access  Restricted Access Subscription or Fee Access

Nanomedicine—Present and Future of Disease Management

Mehamalini V, Divyansh Gupta

Abstract


Nanotechnology presently has many uses in practically every one of the fields. The introduction of nanomedicine has benefitted many research areas in pharmaceutical industries. The usage of nanoparticles in drugs has shown great results that the other drugs did not. In the development of novel medicine, nanotechnology is playing an important role. It is because few medications cannot be used due to complications such as its toxicity, this can be replaced by a nanomedicine. The surface- to-volume ratio of nanomedicine with nanoparticles is greater (aspect ratio). Nanomedicine has shown its effectiveness in both diagnostics and therapeutics. In this review paper, the clinical needs of nanomedicine, drug delivery through nanomedicine has been discussed. Regenerative medicines, current era of nanomedicine, nano surgery has also been explained. Few of the applications of nanomedicine is mentioned.


Keywords


Nanotechnology, Nanomedicine, nanoparticles, Aspect ratio, Diagnostics, Therapeutics, Drug delivery, Regenerative medicine, Nano surgery

Full Text:

PDF

References


Godin, Biana, et al. "Emerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseases." Trends in pharmacological sciences 31.5 (2010): 199-205.

Bharali, Dhruba J., and Shaker A. Mousa. "Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise." Pharmacology & therapeutics 128.2 (2010): 324-335.

Bawa, Raj. "Regulating nanomedicine-can the FDA handle it?" Current drug delivery 8.3 (2011): 227-234.

National Nanotechnology Initiative. "What is nanotechnology? National Nanotechnology Initiative website." (2011).

Hu, LianDong, Xing Tang, and FuDe Cui. "Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs." Journal of Pharmacy and Pharmacology 56.12 (2004): 1527-1535.

Sajja, Hari K., et al. "Development of multifunctional nanoparticles for targeted drug delivery and noninvasive imaging of therapeutic effect." Current drug discovery technologies 6.1 (2009): 43-51.

Poirot-Mazères, Isabelle. egal aspects of the risks raised by nanotechnologies in the field of medicine. ournal International de io thi ue et d thi ue des ciences .1 011 .

Shi, Jinjun, et al. "Cancer nanomedicine: progress, challenges and opportunities." Nature reviews cancer 17.1 (2017): 20-37.

Market Data Forecast “Industry Reports & usiness Intelligence” Market Data Forecast. Published 2022. Accessed July 12, 2022. https://www.marketdataforecast.com/

Center. Vaccines, Blood & Biologics. U.S. Food and Drug Administration. Published 2021. Accessed July 12, 2022. https://www.fda.gov/vaccines-blood-biologics

Emerich, Dwaine F., and Christopher G. Thanos. "Nanotechnology and medicine." Expert opinion on biological therapy 3.4 (2003): 655-663.

Moghimi, S. Moein, A. Christy Hunter, and J. Clifford Murray. "Nanomedicine: current status and future prospects." The FASEB journal 19.3 (2005): 311-330.

Pozzi, Daniela, et al. "Surface chemistry and serum type both determine the nanoparticle–protein corona." Journal of proteomics 119 (2015): 209-217.

Cheng, Mark Ming-Cheng, et al. "Nanotechnologies for biomolecular detection and medical diagnostics." Current opinion in chemical biology 10.1 (2006): 11-19.

Shaffer, Catherine. "Nanomedicine transforms drug delivery." Drug discovery today 10.23-24 (2005): 1581-1582.

Kayser, Oliver, A. Lemke, and Norma Hernandez-Trejo. "The impact of nanobiotechnology on the development of new drug delivery systems." Current pharmaceutical biotechnology 6.1 (2005): 3-5.

Mayer, C. "Nanocapsules as drug delivery systems." The International journal of artificial organs 28.11 (2005): 1163-1171.

Labhasetwar, Vinod. "Nanotechnology for drug and gene therapy: the importance of understanding molecular mechanisms of delivery." Current opinion in biotechnology 16.6 (2005): 674-680.

Ferrari, Mauro, and Gregory Downing. "Medical nanotechnology." BioDrugs 19.4 (2005): 203-210.

Patel, Parmi, and Jigna Shah. "Safety and toxicological considerations of nanomedicines: the Future directions." Current Clinical Pharmacology 12.2 (2017): 73-82.

Arbós, Pau, et al. "Nanoparticles with specific bioadhesive properties to circumvent the pre- systemic degradation of fluorinated pyrimidines." Journal of controlled release 96.1 (2004): 55-65.

Vasir, Jaspreet K., Maram K. Reddy, and Vinod D. Labhasetwar. "Nanosystems in drug targeting:opportunities and challenges." Current Nanoscience 1.1 (2005): 47-64.

Gadekar, Vedant, et al. "Nanomedicines accessible in the market for clinical interventions." Journal of Controlled Release 330 (2021): 372-397.

Wolfram, Joy, and Mauro Ferrari. "Clinical cancer nanomedicine." Nano today 25 (2019): 85-98.

Praetorius, Natalie P., and Tarun K. Mandal. "Engineered nanoparticles in cancer therapy."Recent patents on drug delivery & formulation 1.1 (2007): 37-51.

Wang, Hong, et al. "Nanoparticles-mediated reoxygenation strategy relieves tumor hypoxia for enhanced cancer therapy." Journal of Controlled Release 319 (2020): 25-45.

Wilkinson, J. M. "Nanotechnology applications in medicine." Medical device technology 14.5 (2003): 29-31.




DOI: https://doi.org/10.37628/ijn.v8i1.892

Refbacks

  • There are currently no refbacks.